Volume 20, Number 4—April 2014
Dispatch
Salmonella Subtypes with Increased MICs for Azithromycin in Travelers Returned to the Netherlands
Table
Region |
No. (%) isolates |
No. (%) isolates with elevated MICs |
||
Azithromycin |
Ciprofloxacin |
Azithromycin and ciprofloxacin |
||
All | 205 | 36 (17.6) | 83 (40.5) | 20 (9.8) |
Asia | 161 (78.5) | 31 (19.3) | 80 (49.7) | 20 (12.4) |
Southern Asia* | 84 (40.0) | 21 (25) | 69 (82.1) | 18 (21.4) |
South-Eastern Asia† | 44 (21.5) | 5 (12.2) | 3 (6.8) | 1 (2.3) |
Western Asia‡ | 27 (13.2) | 1 (3.7) | 6 (22.2) | 1 (3.7) |
Eastern Asia§ | 5 (2.4) | 1 (20) | 2 (40) | 0 |
Unknown | 1 (0.5) | 0 | 0 | 0 |
Africa¶ | 35 (17.1) | 5 (14.3) | 1 (2.9) | 0 |
Europe** | 4 (2.0) | 0 | 2 (50) | 0 |
Latin America†† | 5 (2.4) | 0 | 0 | 0 |
*India, Pakistan, Bangladesh, Nepal, Afghanistan, Nepal, Sri Lanka.
†Indonesia, Cambodia, Malaysia, Thailand.
‡Turkey, Iraq, Syria.
§China.
¶Morocco, Ghana, Nigeria, Senegal, Tunisia, Malawi, Tanzania.
**Gibraltar (Great Britain), Greece, Italy, Romania.
††Peru, Mexico, unknown.
Page created: March 18, 2014
Page updated: March 18, 2014
Page reviewed: March 18, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.